CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Clinical trials for CHRONIC OBSTRUCTIVE PULMONARY DISEASE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC OBSTRUCTIVE PULMONARY DISEASE trials appear
Sign up with your email to follow new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New COPD drug TQC2938 aims to cut lung Flare-Ups in half
Disease control OngoingThis study tests an experimental drug called TQC2938 in 256 adults aged 40-80 with moderate to severe COPD. The goal is to see if the drug can reduce the number of serious lung attacks (exacerbations) over 24 weeks compared to a placebo. Participants will be randomly assigned to …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Virtual rehab for COPD: a new way to stay out of the hospital?
Disease control OngoingThis study tests whether a video-based pulmonary rehabilitation program, done from home, can reduce hospital readmissions in people with COPD. About 300 adults hospitalized for a COPD flare-up will either receive the telehealth program or standard care. The goal is to see if the …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New COPD injection aims to cut lung attacks in half
Disease control OngoingThis study tests an experimental drug called TQC2731 in 258 adults aged 40-80 with moderate to severe COPD. Participants receive either the drug or a placebo to see if it reduces the number of serious flare-ups over 24 weeks and improves breathing. The goal is to better control t…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE2 • Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug aims to boost walking distance in lung patients
Disease control OngoingThis study tests an experimental drug called MK-5475 (frespaciguat) in 129 adults who have high blood pressure in the lungs caused by chronic lung disease (COPD). The main goal is to see if the drug helps people walk farther in 6 minutes after 24 weeks compared to a placebo. The …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 14, 2026 12:15 UTC
-
Salmon oil COPD study pulled before it began
Disease control TerminatedThis study aimed to see if a salmon oil supplement called Cardio® could reduce inflammation and lower heart disease risk in people with chronic obstructive pulmonary disease (COPD). It planned to include adults with COPD who smoke or used to smoke. However, the study was withdraw…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Hofseth Biocare ASA • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
Could a simple steroid boost lung health in COPD patients?
Disease control OngoingThis study looks at whether adding an inhaled corticosteroid (ICS) to standard COPD treatment for 4 weeks can improve how well the blood vessels in the lungs work. It involves 30 adults aged 40-80 with COPD who already use a LAMA/LABA inhaler. The main goal is to see if the ICS h…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: PHASE2 • Sponsor: University of Miami • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
Ancient breathing exercises tested for lung disease prevention
Symptom relief OngoingThis study tests whether TCM Daoyin, a traditional Chinese mind-body exercise, can improve lung function and exercise ability in 60 adults at risk for early chronic obstructive pulmonary disease (COPD). Participants will be randomly assigned to either Daoyin training or usual car…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Shanghai University of Traditional Chinese Medicine • Aim: Symptom relief
Last updated May 17, 2026 00:27 UTC
-
E-Cigarettes may ease COPD symptoms for smokers
Symptom relief OngoingThis study looks at whether smokers with mild to moderate COPD who switch to e-cigarettes can reduce their symptoms and risk of flare-ups. About 30 participants will use e-cigarettes to cut down on regular cigarettes. Researchers will track lung function, walking distance, and sy…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: EARLY_PHASE1 • Sponsor: Milton S. Hershey Medical Center • Aim: Symptom relief
Last updated May 17, 2026 00:26 UTC
-
Bringing COPD rehab home: a lifeline for those left behind
Symptom relief OngoingThis study tests two new types of pulmonary rehabilitation—home-based and tele-rehabilitation—for people with COPD who cannot attend standard hospital or community programs. The goal is to see if these options are better than usual care (medication and check-ups) at improving bre…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Copenhagen University Hospital, Hvidovre • Aim: Symptom relief
Last updated May 13, 2026 16:00 UTC
-
AI and heart data aim to predict potassium levels, but study never started
Knowledge-focused TerminatedThis study planned to use a computer program (machine learning) and a simple heart test (single-lead ECG) to predict potassium levels in the blood of hospitalized patients. Researchers would have analyzed data from a previous study at Brigham and Women's Hospital. However, the st…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
AI predicts hospital stays, but study never started
Knowledge-focused TerminatedThis study aimed to see if a computer program could predict how long patients would stay in a home hospital. Researchers planned to use information from past patients to train the computer model. However, the study was withdrawn before any participants were enrolled.
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC
-
Can paying doctors for population health improve COPD outcomes?
Knowledge-focused OngoingThis study looks at whether a new payment system for doctors can help people at high risk for COPD in Xishui, China. About 7,400 adults will be split into two groups. One group gets extra health checks, education, and support for smoking, mental health, and other conditions. The …
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Peking Union Medical College • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
COPD study in egypt canceled before it began
Knowledge-focused TerminatedThis study was designed to track how often people in Egypt have severe COPD flare-ups and how those flare-ups affect their health and healthcare use. It planned to look back at medical records of patients over 40 with COPD for at least three years. However, the study was withdraw…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC
-
New study investigates if bundled payments improve care and cut costs
Knowledge-focused OngoingThis study looks at a new way of paying for healthcare called bundled payments, where providers get a single payment for an entire episode of care. Researchers will analyze Medicare data from 440 provider organizations to see if this approach improves quality and reduces costs fo…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC
-
Smart wristband could spot COPD attacks before they start
Knowledge-focused OngoingThis study tests a wristband that monitors people with COPD at home. The goal is to see if it can detect early signs of a flare-up (sudden worsening of symptoms). 64 participants wore the device, and researchers checked how well it spotted these events. The study does not offer a…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC
-
Lung bacteria linked to COPD progression in new study
Knowledge-focused OngoingThis study looks at how tiny organisms in the lungs (airway microecology) are related to the development and changes of chronic obstructive pulmonary disease (COPD). Researchers will collect lung fluid from 210 adults with or at risk for COPD and track their lung function and sym…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Knowledge-focused
Last updated May 13, 2026 15:59 UTC
-
Massive COPD study aims to unravel lung disease mysteries
Knowledge-focused OngoingThis study follows nearly 3,000 people with COPD (a lung disease) and some healthy smokers and non-smokers over several years. Researchers are collecting health data, lung function tests, and imaging to find patterns in how COPD progresses and to develop better ways to measure th…
Matched conditions: CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated May 07, 2026 18:42 UTC